Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy. [electronic resource]
Producer: 20100617Description: 947-954.e1 p. digitalISSN:- 1879-1891
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Choroid -- blood supply
- Choroid Diseases -- diagnosis
- Combined Modality Therapy
- Female
- Fluorescein Angiography
- Humans
- Injections
- Male
- Middle Aged
- Peripheral Vascular Diseases -- diagnosis
- Photochemotherapy
- Photosensitizing Agents -- therapeutic use
- Porphyrins -- therapeutic use
- Retreatment
- Retrospective Studies
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Verteporfin
- Visual Acuity -- physiology
- Vitreous Body
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.